TRPharm Chair: 'Dr Reddy's Partnership Is Key To International Expansion'

Turkey's TRPharm, in partnership with India's Dr Reddy's, has become the first company to gain a license for an oncology biosimilar Mab product in Turkey. Chairman Mehmet Göker spoke to Scrip about the company's international expansion plans.

Turkish flag

More from Biosimilars

More from Products